Shoji Hirokazu 庄司広和

Researcher Number	50765568
Other IDs	https://orcid.org/0000-0002-8922-5227
Affiliation (Current)	2025: 国立研究開発法人国立がん研究センター, 中央病院, 医長
Affiliation (based on the past Project Information) *help	2023: 国立研究開発法人国立がん研究センター, 中央病院, 医長 2016 – 2022: 国立研究開発法人国立がん研究センター, 中央病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related / Gastroenterology
Keywords	Principal Investigator 次世代シークエンス / オミクス解析 / リキッドバイオプシー / 消化管がん / 末梢循環腫瘍細胞 / 治療抵抗性の克服 / リン酸化プロテオゲノミクス解析 / BRAFV600E変異陽性大腸癌 / 精密医療 / スフェロイド培養 … More / 免疫チェックポイント阻害薬 / 胃がん / nivolumab / tumor mutation burden / 胃癌 / バイオマーカー / 1細胞オミクス解析 / liquid biopsy / gastrointestinal cancer / circulating tumor DNA / circulating tumor cell Less

Using phosphoproteogenomics analysis to elucidate resistance to therapy in BRAF mutated colorectal cancerPrincipal Investigator
- Principal Investigator
  
  庄司広和
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  National Cancer Center Japan
Precision medicine using circulating tumor cells of gastrointestinal cancerPrincipal Investigator
- Principal Investigator
  
  Shoji Hirokazu
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  National Cancer Center Japan
Search for pathological diagnosis using circulation tumor cells in gastrointestinal cancerPrincipal Investigator
- Principal Investigator
  
  Shoji Hirokazu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  National Cancer Center Japan

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 Other

All Journal Article Presentation Other

[Journal Article] Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID)2024
- Author(s)
  Arai H, Tsuda T, Sunakawa Y, Shimokawa M, Akiyoshi K, Tokunaga S, Shoji H, Kunieda K, Kotaka M, Matsumoto T, Nagata Y, Mizukami T, Mizuki F, Danenberg KD, Boku N, Nakajima TE.
- Journal Title
  
  Cancer Med .
  
  Volume: 13(7) Issue: 7
- DOI
  10.1002/cam4.7107
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] 10.62347/NQBL9998. eCollection 2024.2024
- Author(s)
  Oshima K, Shoji H, Boku N, Hirano H, Okita N, Takashima A, Kato K, Kudo-Saito C.
- Journal Title
  
  Am J Cancer Res.
  
  Volume: 14(3) Issue: 3 Pages: 1174-1189
- DOI
  10.62347/nqbl9998
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab2024
- Author(s)
  Wakatsuki T, Ishizuka N, Hironaka S, Minashi K, Kadowaki S, Goto M, Shoji H, Hirano H, Nakayama I, Osumi H, Ogura M, Chin K, Yamaguchi K, Takahari D.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: － Issue: 6 Pages: 801-812
- DOI
  10.1007/s10147-024-02509-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer2024
- Author(s)
  Shitara K, Fleitas T, Kawakami H, Shoji H, et al.
- Journal Title
  
  ESMO Open.
  
  Volume: 9(2) Issue: 2 Pages: 102226-102226
- DOI
  10.1016/j.esmoop.2023.102226
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan2023
- Author(s)
  Aoki M, Kadowaki S, Takahashi N, Suzuki T, Oshima K, Ando T, Yamamoto Y, Kawakami K, Kito Y, Matsumoto T, Shimozaki K, Miyazaki Y, Yamaguchi T, Nagase M, Tamura T, Amanuma Y, Esaki T, Miura Y, Akiyoshi K, Baba E, Makiyama A, Negoro Y, Nakashima K, Sugimoto N, Nagashima K, Shoji H, Boku N.
- Journal Title
  
  Gastric Cancer.
  
  Volume: Jan;26(1) Issue: 1 Pages: 132-144
- DOI
  10.1007/s10120-022-01349-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Recent advances in immunotherapy and molecular targeted therapy for gastric cancer2023
- Author(s)
  Yoshinami Y, Shoji H.
- Journal Title
  
  Future Sci OA.
  
  Volume: Mar 17;9(2) Issue: 2
- DOI
  10.2144/fsoa-2023-0002
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Progression patterns and site-specific responses in advanced gastric cancer patients treated with nivolumab2023
- Author(s)
  Kadono T, Iwasa S, Nagashima K, Oshima K, Yamamoto S, Hirano H, Okita N, Shoji H, Honma Y, Takashima A, Kato K, Ushijima T, Boku N.
- Journal Title
  
  Cancer Med.
  
  Volume: Feb 15. Issue: 8 Pages: 9322-9331
- DOI
  10.1002/cam4.5689
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Integration of pharmacoproteomic and computational approaches reveals the cellular signal transduction pathways affected by apatinib in gastric cancer cell lines.2023
- Author(s)
  Nojima, Y., Aoki, M., Re, S., Hirano, H., Abe, Y., Narumi, R., Muraoka, S., Shoji, H., Honda, K., Tomonaga, T., Mizuguchi, K., Boku, N., and Adachi, J.
- Journal Title
  
  Comput Struct Biotechnol J
  
  Volume: 21 Pages: 2172-2187
- DOI
  10.1016/j.csbj.2023.03.006
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H03544, KAKENHI-PROJECT-20K07333, KAKENHI-PROJECT-20K15422, KAKENHI-PROJECT-20K17069, KAKENHI-PROJECT-23K20389, KAKENHI-PROJECT-22K08068
[Journal Article] Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study2023
- Author(s)
  Takahari D, Katai H, Takashima A, Izawa N, Ishizuka N, Ohashi M, Mikami S, Wakatsuki T, Nakayama I, Chin K, Ida S, Kumagai K, Nunobe S, Iwasa S, Shoji H, Wada T, Doi A, Yoshikawa T, Sano T, Boku N, Yamaguchi K.
- Journal Title
  
  Gastric Cancer.
  
  Volume: Apr 8 Issue: 4 Pages: 614-625
- DOI
  10.1007/s10120-023-01388-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer2022
- Author(s)
  Oshima K, Hirano H, Shoji H, Iwasa S, Okita N, Takashima A, Boku N.
- Journal Title
  
  PLoS One
  
  Volume: Jun 2;17(6) Issue: 6 Pages: e0269115-e0269115
- DOI
  10.1371/journal.pone.0269115
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part)2022
- Author(s)
  Kikuchi K, Yamazaki N, Nozawa K, Fukuda H, Shibata T, Machida R, Hamaguchi T, Takashima A, Shoji H, Boku N, Takatsuka S, Takenouchi T, Nishina T, Yoshikawa S, Takahashi M, Hasegawa A, Kawazoe A, Masuishi T, Mizutani H, Kiyohara Y.
- Journal Title
  
  Support Care Cancer.
  
  Volume: 30(5) Issue: 5 Pages: 4497-4504
- DOI
  10.1007/s00520-022-06874-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Clinical outcomes of surgical and imatinib treatment for rectal gastrointestinal stromal tumours: retrospective cohort study2022
- Author(s)
  Tsukamoto S, Honma Y, Shoji H, Hirano H, Inoue M, Takamizawa Y, Moritani K, Imaizumi J, Kanemitsu Y.
- Journal Title
  
  BJS Open.
  
  Volume: May 2;6(3) Issue: 3
- DOI
  10.1093/bjsopen/zrac067
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer2022
- Author(s)
  Hirano H, Abe Y, Nojima Y, Aoki M, Shoji H, Isoyama J, Honda K, Boku N, Mizuguchi K, Tomonaga T, Adachi J.
- Journal Title
  
  Sci Rep.
  
  Volume: 12(1) Issue: 1 Pages: 4419-4419
- DOI
  10.1038/s41598-022-08430-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432, KAKENHI-PROJECT-20H03544, KAKENHI-PROJECT-20H03749, KAKENHI-PROJECT-20K15422, KAKENHI-PROJECT-20K07333, KAKENHI-PROJECT-20K17069, KAKENHI-PROJECT-23K20389, KAKENHI-PROJECT-19H03856
[Journal Article] Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer2022
- Author(s)
  Kudo-Saito C, Boku N, Hirano H, Shoji H.
- Journal Title
  
  Front Immunol.
  
  Volume: Sep 23;13 Pages: 1009701-1009701
- DOI
  10.3389/fimmu.2022.1009701
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08068
[Journal Article] A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)2021
- Author(s)
  Shoji H, Takahari D, Hara H, Nagashima K, Adachi J, Boku N.
- Journal Title
  
  Future Sci OA.
  
  Volume: 7(7) Issue: 7 Pages: 721-721
- DOI
  10.2144/fsoa-2021-0023
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study2021
- Author(s)
  Ishikawa M, Takashima A, Nagata Y, Sawada R, Aoki M, Imazeki H, Hirano H, Shoji H, Honma Y, Iwasa S, Okita N, Kato K, Saruta M, Boku N.
- Journal Title
  
  PLoS One.
  
  Volume: 16(9) Issue: 9 Pages: e0257551-e0257551
- DOI
  10.1371/journal.pone.0257551
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer2021
- Author(s)
  Takamizawa S, Shoji H, Hirano H, Izutsu K, Yamamoto S, Iwasa S, Honma Y, Okita N, Takashima A, Kato K, Boku N.
- Journal Title
  
  Case Rep Oncol.
  
  Volume: 14(1) Issue: 1 Pages: 85-89
- DOI
  10.1159/000512821
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] REVIVE study: a prospective observational study in chemotherapy after nivolumab therapy for advanced gastric cancer2021
- Author(s)
  Narita Y, Shoji H, Kawai S, Mizukami T, Nakamura M, Moriwaki T, Yamanaka T, Sunakawa Y, Kawakami H, Nishina T, Misumi T, Muro K.
- Journal Title
  
  Future Oncol.
  
  Volume: 17(8) Issue: 8 Pages: 869-875
- DOI
  10.2217/fon-2020-0621
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy2020
- Author(s)
  Tamura N, Honma Y, Sekine S, Tsukamoto S, Hirano H, Okita N, Shoji H, Iwasa S, Takashima A, Kato K, Boku N.
- Journal Title
  
  Oxf Med Case Reports.
  
  Volume: 2020(11) Issue: 11
- DOI
  10.1093/omcr/omaa097
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.2020
- Author(s)
  Nagata Y, Kato K, Miyamoto T, Hirano H, Shoji H, Iwasa S, Honma Y, Takashima A, Hamaguchi T, Matsushita H, Nagashima K, Saruta M, Boku N.
- Journal Title
  
  Support Care Cancer
  
  Volume: Epub ahead of print Issue: 12 Pages: 5861-5869
- DOI
  10.1007/s00520-020-05401-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens.2020
- Author(s)
  Abe Y, Hirano H, Shoji H, Tada A, Isoyama J, Kakudo A, Gunji D, Honda K, Boku N, Adachi J, Tomonaga T.
- Journal Title
  
  Theranostics
  
  Volume: 10（5） Issue: 5 Pages: 2115-2129
- DOI
  10.7150/thno.37623
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432, KAKENHI-PROJECT-20H03544, KAKENHI-PROJECT-19H03856
[Journal Article] Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology.2020
- Author(s)
  Aoki M, Shoji H, Kashiro A, Takeuchi K, Shimizu Y, Honda K.
- Journal Title
  
  Cancers (Basel)
  
  Volume: 12（5） Issue: 5 Pages: 1135-1135
- DOI
  10.3390/cancers12051135
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432, KAKENHI-PROJECT-19H03856
[Journal Article] Survival Outcomes of Resected BRAF V600E Mutant Colorectal Liver Metastases: A Multicenter Retrospective Cohort Study in Japan2020
- Author(s)
  Kobayashi S, Takahashi S, Takahashi N, Masuishi T, Shoji H, Shinozaki E, Yamaguchi T, Kojima M, Gotohda N, Nomura S, Yoshino T, Taniguchi H.
- Journal Title
  
  Ann Surg Oncol.
  
  Volume: 27(9) Issue: 9 Pages: 3307-3315
- DOI
  10.1245/s10434-020-08817-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08432, KAKENHI-PROJECT-18K07035
[Journal Article] Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.2020
- Author(s)
  Nakatani Y, Kato K, Shoji H, Iwasa S, Honma Y, Takashima A, Ushijima T, Ito Y, Itami J, Boku N.
- Journal Title
  
  Int J Clin Oncol
  
  Volume: Epub ahead of print Issue: 6 Pages: 1098-1104
- DOI
  10.1007/s10147-020-01652-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] IL33 Is a Key Driver of Treatment Resistance of Cancer.2020
- Author(s)
  Kudo-Saito C, Miyamoto T, Imazeki H, Shoji H, Aoki K, Boku N.
- Journal Title
  
  Cancer Res
  
  Volume: Epub ahead of print Issue: 10 Pages: 1981-1990
- DOI
  10.1158/0008-5472.can-19-2235
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Serum level of octanoic acid predicts the efficacy of chemotherapy for colorectal cancer.2019
- Author(s)
  Iemoto T, Nishiumi S, Kobayashi T, Fujigaki S, Hamaguchi T, Kato K, Shoji H, Matsumura Y, Honda K, Yoshida M.
- Journal Title
  
  Oncol Lett.
  
  Volume: 17(1) Pages: 831-842
- DOI
  10.3892/ol.2018.9731
- NAID
  120006554635
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.2019
- Author(s)
  Masuda K, Shoji H, Nagashima K, Yamamoto S, Ishikawa M, Imazeki H, Aoki M, Miyamoto T, Hirano H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Boku N.
- Journal Title
  
  BMC Cancer
  
  Volume: 19（1） Issue: 1 Pages: 974-974
- DOI
  10.1186/s12885-019-6150-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer.2019
- Author(s)
  Aoki M, Shoji H, Nagashima K, Imazeki H, Miyamoto T, Hirano H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Higuchi K, Boku N.
- Journal Title
  
  ESMO Open
  
  Volume: 4（3） Issue: 3 Pages: e000488-e000488
- DOI
  10.1136/esmoopen-2019-000488
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08432
[Journal Article] Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report.2019
- Author(s)
  Watanabe S, Honma Y, Murakami N, Igaki H, Mori T, Hirano H, Okita N, Shoji H, Iwasa S, Takashima A, Kato K, Kobayashi K, Matsumoto F, Yoshimoto S, Itami J, Boku N.
- Journal Title
  
  World J Clin Cases.
  
  Volume: 7(6) Issue: 6 Pages: 765-772
- DOI
  10.12998/wjcc.v7.i6.765
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16K10410
[Journal Article] CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation.2019
- Author(s)
  Honda K, Katzke VA, Hüsing A, Okaya S, Shoji H, et al.
- Journal Title
  
  Int J Cancer.
  
  Volume: 144（8） Issue: 8 Pages: 1877-1887
- DOI
  10.1002/ijc.31900
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H05547
[Journal Article] Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.2019
- Author(s)
  Nishiumi S, Fujigaki S, Kobayashi T, Kojima T, Ito Y, Daiko H, Kato K, Shoji H, Kodama Y, Honda K, Yoshida M.
- Journal Title
  
  Anticancer Res.
  
  Volume: 39(1) Issue: 1 Pages: 519-526
- DOI
  10.21873/anticanres.13143
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H05547
[Journal Article] Live single cell mass spectrometry reveals cancer‐specific metabolic profiles of circulating tumor cells2019
- Author(s)
  Abouleila Yasmine、Onidani Kaoru、Ali Ahmed、Shoji Hirokazu、Kawai Takayuki、Lim Chwee Teck、Kumar Vipin、Okaya Shinobu、Kato Ken、Hiyama Eiso、Yanagida Toshio、Masujima Tsutomu、Shimizu Yoshihiro、Honda Kazufumi
- Journal Title
  
  Cancer Science
  
  Volume: 110 Issue: 2 Pages: 697-706
- DOI
  10.1111/cas.13915
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PUBLICLY-17H05680, KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H02778, KAKENHI-PROJECT-16H05547, KAKENHI-PROJECT-19H01056, KAKENHI-PROJECT-19H03856
[Journal Article] Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer.2019
- Author(s)
  Yamaguchi T, Iwasa S, Shoji H, Honma Y, Takashima A, Kato K, Hamaguchi T, Higuchi K, Boku N.
- Journal Title
  
  Gastric Cancer.
  
  Volume: 印刷中 Issue: 4 Pages: 778-784
- DOI
  10.1007/s10120-018-00917-5
- NAID
  40021925970
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA2019
- Author(s)
  Onidani Kaoru、Shoji Hirokazu、Kakizaki Takahiko、Yoshimoto Seiichi、Okaya Shinobu、Miura Nami、Sekikawa Shoichi、Furuta Koh、Lim Chwee Teck、Shibahara Takahiko、Boku Narikazu、Kato Ken、Honda Kazufumi
- Journal Title
  
  Cancer Science
  
  Volume: 110 Issue: 8 Pages: 2590-2599
- DOI
  10.1111/cas.14092
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07341, KAKENHI-PROJECT-19K08432, KAKENHI-PROJECT-17K11888, KAKENHI-PROJECT-19H03856
[Journal Article] A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma.2018
- Author(s)
  Hiramoto S, Kato K, Shoji H, Okita N, Takashima A, Honma Y, Iwasa S, Hamaguchi T, Yamada Y, Shimada Y, Boku N.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 印刷中 Issue: 3 Pages: 466-472
- DOI
  10.1007/s10147-018-1239-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.2018
- Author(s)
  Sekine K, Hamaguchi T, Shoji H, Takashima A, Honma Y, Iwasa S, Kato K, Takahashi K, Kato T, Kanemitsu Y, Boku N.
- Journal Title
  
  Oncology.
  
  Volume: 95（4） Issue: 4 Pages: 220-228
- DOI
  10.1159/000489665
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.2018
- Author(s)
  Ida H, Honma Y, Hirano H, Shoji H, Iwasa S, Okita N, Takashima A, Kato K, Fukuda T, Boku N.
- Journal Title
  
  Invest New Drugs.
  
  Volume: 印刷中 Issue: 3 Pages: 573-578
- DOI
  10.1007/s10637-018-0669-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.2018
- Author(s)
  Sudo K, Kato K, Kuwabara H, Sasaki Y, Takahashi N, Shoji H, Iwasa S, Honma Y, Okita NT, Takashima A, Hamaguchi T, Yamada Y, Ito Y, Itami J, Fukuda T, Tobinai K, Boku N.
- Journal Title
  
  Oncology.
  
  Volume: 94（1） Issue: 1 Pages: 47-54
- DOI
  10.1159/000480515
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-17K15010
[Journal Article] Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer2018
- Author(s)
  Shoji Hirokazu、Miura Nami、Ueno Hideki、Honda Kazufumi
- Journal Title
  
  Pancreatology
  
  Volume: 18 Issue: 6 Pages: 624-629
- DOI
  10.1016/j.pan.2018.06.003
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07341, KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H05547
[Journal Article] Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.2017
- Author(s)
  Kakuya T, Mori T, Yoshimoto S, Watabe Y, Miura N, Shoji H, Onidani K, Shibahara T, Honda K.
- Journal Title
  
  Int J Oral Maxillofac Surg.
  
  Volume: 46（8） Issue: 8 Pages: 968-976
- DOI
  10.1016/j.ijom.2017.03.001
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H05547, KAKENHI-PROJECT-16K15833
[Journal Article] The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy.2017
- Author(s)
  Shoji H, Tada k, Kitano S, Nishimura T, Shimada Y, Nagashima K, Aoki K, Hiraoka N, Honma Y, Iwasa S, Takashima A, Kato K, Boku N, Honda K, Yamada T, Heike Y, and Hamaguchi T.
- Journal Title
  
  Oncotarget.
  
  Volume: In press
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy2017
- Author(s)
  Shoji Hirokazu、Tada Kohei、Kitano Shigehisa、Nishimura Takashi、Shimada Yasuhiro、Nagashima Kengo、Aoki Kazunori、Hiraoka Nobuyoshi、Honma Yoshitaka、Iwasa Satoru、Takashima Atsuo、Kato Ken、Boku Narikazu、Honda Kazufumi、Yamada Tesshi、Heike Yuji、Hamaguchi Tetsuya
- Journal Title
  
  Oncotarget
  
  Volume: 8 Issue: 56 Pages: 95083-95094
- DOI
  10.18632/oncotarget.18297
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07208, KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H05547, KAKENHI-PROJECT-16K15833
[Journal Article] Circulating tumor cellの同定と、その臨床応用2017
- Author(s)
  庄司広和、鬼谷薫、吉本世一、本田一文、加藤健
- Journal Title
  
  腫瘍内科
  
  Volume: 19(4) Pages: 422-427
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.2017
- Author(s)
  Honma Y, Hokamura N, Nagashima K, Sudo K, Shoji H, Iwasa S, Takashima A, Kato K, Hamaguchi T, Boku N, Umezawa R, Ito Y, Itami J, Koyanagi K, Igaki H, Tachimori Y.
- Journal Title
  
  Anticancer Res.
  
  Volume: 37（7） Pages: 3741-3749
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients.2016
- Author(s)
  Tada K, Kitano S, Shoji H, Nishimura T, Shimada Y, Nagashima K, Aoki K, Hiraoka N, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Yamada Y, Katayama N, Boku N, Heike Y, Hamaguchi T.
- Journal Title
  
  Cancer immunology research
  
  Volume: 4(7) Issue: 7 Pages: 592-599
- DOI
  10.1158/2326-6066.cir-15-0298
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26460981, KAKENHI-PROJECT-16K08752, KAKENHI-PROJECT-16K19381
[Journal Article] Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies.2016
- Author(s)
  Takahashi N, Iwasa S, Taniguchi H, Sasaki Y, Shoji H, Honma Y, Takashima A, Okita N, Kato K, Hamaguchi T, Shimada Y, and Yamada Y.
- Journal Title
  
  Br J Cancer.
  
  Volume: Apr 26;114(9) Issue: 9 Pages: 1003-11
- DOI
  10.1038/bjc.2016.74
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis.2016
- Author(s)
  Sasaki Y, Hamaguchi T, Yamada Y, Takahashi N, Shoji H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Nagai Y, Taniguchi H, Boku N, Ushijima T, and Shimada Y.
- Journal Title
  
  Asian Pac J Cancer Prev.
  
  Volume: 17(2) Pages: 539-43
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer.2016
- Author(s)
  Takahashi N, Furuta K, Taniguchi H, Sasaki Y, Shoji H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Hamaguchi T, Shimada Y, and Yamada Y.
- Journal Title
  
  Oncotarget.
  
  Volume: Jan 26;7(4) Issue: 4 Pages: 4925-38
- DOI
  10.18632/oncotarget.6753
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.2016
- Author(s)
  Shoji H, Morizane C, Sakamoto Y, Kondo S, Ueno H, Takahashi H, Ohno I, Shimizu S, Mitsunaga S, Ikeda M, Okusaka T.
- Journal Title
  
  Japanese journal of clinical oncology
  
  Volume: 46 Pages: 132-137
- DOI
  10.1093/jjco/hyv179
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26860537, KAKENHI-PROJECT-16K19381
[Journal Article] 血液apolipoprotein-A2 isoforms による早期膵がんの診断2016
- Author(s)
  鬼谷薫、庄司広和、本田一文
- Journal Title
  
  がん分子標的治療
  
  Volume: 14(4) Pages: 108-113
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer.2016
- Author(s)
  Yamaguchi T, Iwasa S, Nagashima K, Ikezawa N, Hamaguchi T, Shoji H, Honma Y, Takashima A, Okita N, Kato K, Yamada Y, and Shimada Y.
- Journal Title
  
  Anticancer Res.
  
  Volume: Jul;36(7) Pages: 3531-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.2016
- Author(s)
  Takahashi N, Iwasa S, Sasaki Y, Shoji H, Honma Y, Takashima A, Okita NT, Kato K, Hamaguchi T, and Yamada Y.
- Journal Title
  
  J Cancer Res Clin Oncol.
  
  Volume: Aug;142(8) Issue: 8 Pages: 1727-38
- DOI
  10.1007/s00432-016-2184-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K19381
[Journal Article] Efficacy of adjuvant chemotherapy for non-small cell lung cancer assesed by metastatic potential assocaited with ACTN42016
- Author(s)
  Miura N, Kamita M, Kakuya T, Fujiwara Y, Tsuta K, Shiraishi H, Takeshita F, Ochiya T, Hirokazu Shoji, Huang W, Ohe Y, Yamada T, Honda K
- Journal Title
  
  Oncotarget
  
  Volume: Apr 21 Issue: 22 Pages: 1-14
- DOI
  10.18632/oncotarget.8890
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23390469, KAKENHI-PROJECT-15K15751, KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H05547
[Journal Article] A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab.2016
- Author(s)
  Takahashi N, Iwasa S, Fukahori M, Sudo K, Sasaki Y, Shoji H, Honma Y, Okita NT, Takashima A, Hamaguchi T, Boku N, Shimada Y, Honda K, Yamada T, and Yamada Y.
- Journal Title
  
  Cancer Chemother Pharmacol.
  
  Volume: Sep;78(3) Issue: 3 Pages: 567-75
- DOI
  10.1007/s00280-016-3111-x
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381, KAKENHI-PROJECT-16H05547
[Journal Article] Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.2016
- Author(s)
  Iwasa S, Yamada Y, Heike Y, Shoji H, Honma Y, Komatsu N, Matsueda S, Yamada A, Morita M, Yamaguchi R, Tanaka N, Kawahara A, Kage M, Shichijo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Issue: 5 Pages: 590-600
- DOI
  10.1111/cas.12919
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K19381
[Presentation] Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy2023
- Author(s)
  Hirokazu Shoji, Masahiko Aoki, Hidekazu Hirano, Yuichi Abe, Ryohei Narumi, Kazufumi Honda, Takeshi Tomonaga, Kenji Mizuguchi, Takaki Yoshikawa, Narikazu Boku, and Jun Adachi
- Organizer
  AACR
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08068
[Presentation] Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy2023
- Author(s)
  Hirokazu Shoji, Masahiko Aoki, Hidekazu Hirano, Yuichi Abe, Ryohei Narumi, Kazufumi Honda, Takeshi Tomonaga, Kenji Mizuguchi, Takaki Yoshikawa, Narikazu Boku, and Jun Adachi
- Organizer
  AACR2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08068
[Presentation] Temporal dynamics of phosphoproteomics using endoscopic biopsy specimens in stage IV gastric cancer2022
- Author(s)
  Hidekazu Hirano, Yuichi Abe, Yosui Nojima, Masahiko Aoki, Hirokazu Shoji, Junko Isoyama, Kazufumi Honda, Narikazu Boku, Kenji Mizuguchi, Takeshi Tomonaga, Jun Adachi
- Organizer
  JGCA
- Data Source
  KAKENHI-PROJECT-19K08432
[Presentation] Profiling of myeloid cells associated with prognosis in nivolumab monotherapy for advanced gastric cancer (WJOG10417GTR study)2022
- Author(s)
  Hirokazu Shoji; Narikazu Boku; Chie Kudo-Saito; Kengo Nagashima; Kai Tsugaru; Naoki Takahashi; Takeshi Kawakami; Yusuke Amanuma; Takeru Wakatsuki; Naohiro Okano; Yukiya Narita; Yoshiyuki Yamamoto; Rika Kizawa; Hiroshi Imazeki; Kazunori Aoki; Kei Muro
- Organizer
  ESMO2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08068
[Presentation] Safety and early efficacy of nivolumab plus trastuzumab with FU plus oxaliplatin for HER2-positive gastric cancer2022
- Author(s)
  Hirokazu Shoji, Daisuke Takahari, Keiko Minashi, Hiroki Hara, Keisho Chin, Akira Ooki, Mariko Ogura, Izuma Nakayama, Ken Kato, Satoru Iwasa, Hidekazu Hirano, Yusuke Amanuma, Naoki Ishizuka, Narikazu Boku,Kensei Yamaguchi
- Organizer
  JSMO
- Data Source
  KAKENHI-PROJECT-19K08432
[Presentation] Search of biomarkers and creation of innovative methods required for precision medicine for gastric cancer2021
- Author(s)
  Shoji H, Adachi J, Hirano H, Honda K, Mizuguchi K, Tomonaga T, Boku N
- Organizer
  第18回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-19K08432
[Presentation] 血液検体を用いたリキッドバイオプシーの有用性2020
- Author(s)
  庄司広和
- Organizer
  第33回日本口腔診断学会第30回日本口腔内科学会第13回日本口腔検査学会合同学術大会.
- Invited
- Data Source
  KAKENHI-PROJECT-19K08432
[Presentation] Comprehensive phosphoproteomics using gastric cancer biopsy specimens.2019
- Author(s)
  H. Shoji, Y. Abe, H. Hirano, J. Adachi, M. Aoki, K. Honda, N. Boku, T. Tomonaga
- Organizer
  13th International Gastric Cancer Congress 2019 (IGCC 2019)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08432
[Presentation] The hyperprogressive disease during nivolumab treatment or irinotecan treatment in patients with advanced gastric cancer.2019
- Author(s)
  Aoki M, Shoji H, Imazeki H, Miyamoto T, Hirano H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Boku N.
- Organizer
  2019 ASCO Gastrointestinal Cancers Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Phase 1/2 study of ramucirumab plus nivolumab in patients in second line treatment for advanced　gastric adenocarcinoma (NivoRam study).2019
- Author(s)
  Hara H, Shoji H, Takahari D, Esaki T, Machida N, Nagashima K, Aoki K,　Honda K, Miyamoto T, Boku N, Kato K.
- Organizer
  2019 ASCO Gastrointestinal Cancers Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Survival impact of the response at 12 weeks in patients with advanced gastric cancer received firstline chemotherapy.2019
- Author(s)
  Arakaki M, Aoki M, Imazeki H, Shoji H, Honma Y, Iwasa S, Okita N,Takashima A, Kato K, Boku N.
- Organizer
  2019 ASCO Gastrointestinal Cancers Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Preliminary result of phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma (NivoRam study)2018
- Author(s)
  Takahari D, Shoji H, Hara H, Esaki T, Machida N, Nagashima K, Aoki K, Honda K, Miyamoto T, Boku N, Kato K.
- Organizer
  2018 ASCO annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Expression of B7-H3 (CD276) in surgically resected esophageal squamous cell carcinoma2018
- Author(s)
  Maruki Y, Takashima A, Miyamoto T, Hirano H, Shoji H, Honma Y, Iwasa S, Okita N, Kato K, Sekine S, Koyanagi K, Daiko H, Kitano S, Aoki K, Boku N
- Organizer
  American Society of Clinical Oncology 2018 Gastrointesinal Cancer Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] 次世代シーケンサーによる血中循環腫瘍細胞(CTCs)および血中腫瘍循環DNA(ctDNA)のリアルタイムモニタリング2018
- Author(s)
  鬼谷薫、庄司広和、吉本世一、三浦奈美、柴原孝彦、加藤健、本田一文
- Organizer
  日本分子腫瘍マーカー研究会
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Next-generation sequencing of circulating tumor cells isolated from peripheral blood of patients with head and neck or gastrointestinal cancer.2017
- Author(s)
  Onidani K, Yoshimoto S, Miura N, Shoji H, Kato K, Shibahara T, Honda K.
- Organizer
  European Society for Medical Oncology 2017 Congress Asia 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Evaluation of the safety and efficacy of combined the KM-CART and chemotherapy for gastrointestinal cancers with massive ascites.2017
- Author(s)
  Y. Nagata, K. Kato, H. Matsushita, T. Yamaguchi, T. Miyamoto,　H. Shoji, S. Iwasa, Y. Honma, A. Takashima, T. Hamaguchi, M. Saruta, N. Boku
- Organizer
  European Society for Medical Oncology 2017 Congress Asia 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] A phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma.2017
- Author(s)
  Shoji H, Miyamoto H, Takahari D, Hara H, Machida N, Esaki T, Nagashima K, Aoki K, Honda K, Nagata Y, Miyamoto T, Boku N, Kato K.
- Organizer
  日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] 次世代シーケンサーによる血中循環腫瘍細胞(CTCs)の遺伝子変異プロファイリング2017
- Author(s)
  鬼谷　薫、吉本世一、三浦奈美、庄司広和、加藤　健、柴原孝彦、本田一文
- Organizer
  日本分子腫瘍マーカー研究会
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Possibility of a novel molecular therapeutic target for tongue cancer.2017
- Author(s)
  Onidani K, Kakuya T, Watabe Y, Miura N, Shoji H, Shibahara T, Honda K.
- Organizer
  Human Proteome Organisation World Congress 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] A phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma.2017
- Author(s)
  Shoji H, Miyamoto H, Takahari D, Hara H, Machida N, Esaki T, Nagashima K, Aoki K, Honda K, Nagata Y, Miyamoto T, Boku N, Kato K.
- Organizer
  European Society for Medical Oncology 2017 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.2017
- Author(s)
  Onidani K, Kakuya T, Miura N, Shoji H, Shibahara T, Honda K.
- Organizer
  日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Next-generation sequencing of circulating tumor cells isolated from peripheral blood of patients with head and neck or gastrointestinal cancer2016
- Author(s)
  H.Shoji, K.Kato, S.Yoshimoto, F.Kakizaki, K.Furuta, K.Onidani, N.Miura, K.Honda.
- Organizer
  ESMO 2016 Congress
- Place of Presentation
  Copenhagen, Denmark
- Year and Date
  2016-10-07
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[Presentation] Assessment of efficacy of adjuvant chemotherapy for non-small cell lung cancer with metastatic ability involving ACTN42016
- Author(s)
  K.Honda, N.Miura, H.Shiraishi, K.Onidani, H.Shoji, T.Yamada, Y.Fujiwara, Y.Ohe
- Organizer
  ESMO 2016 Congress
- Place of Presentation
  Copenhagen, Denmark
- Year and Date
  2016-10-07
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19381
[]

1. 本田一文 (10260936)

# of Collaborated Projects: 3 results

# of Collaborated Products: 28 results
2. 足立淳 (20437255)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. KITANO Shigehisa

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
4. BOKU Narikazu

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. SHOJI Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. SHIMIZU Yoshihiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 近藤俊輔

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 朝長毅

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 笹田哲朗

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 松枝智子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 三浦奈美

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

Shoji Hirokazu 庄司 広和

Research Projects

Research Products

Co-Researchers

Using phosphoproteogenomics analysis to elucidate resistance to therapy in BRAF mutated colorectal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Precision medicine using circulating tumor cells of gastrointestinal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Search for pathological diagnosis using circulation tumor cells in gastrointestinal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID)2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 10.62347/NQBL9998. eCollection 2024.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Recent advances in immunotherapy and molecular targeted therapy for gastric cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Progression patterns and site-specific responses in advanced gastric cancer patients treated with nivolumab2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Integration of pharmacoproteomic and computational approaches reveals the cellular signal transduction pathways affected by apatinib in gastric cancer cell lines.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part)2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical outcomes of surgical and imatinib treatment for rectal gastrointestinal stromal tumours: retrospective cohort study2022

Author(s)

Journal Title

Shoji Hirokazu 庄司広和